Sangamo Therapeutics Profit Margin 2006-2021 | SGMO
Current and historical gross margin, operating margin and net profit margin for Sangamo Therapeutics (SGMO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Sangamo Therapeutics net profit margin as of June 30, 2021 is -98.21%.
|Sangamo Therapeutics Annual Profit Margins
|Sangamo Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc., formerly known as Sangamo BioSciences Inc., is based in Richmond, United States.